VTGN Earnings Vistagen Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–37 of 37
| Q1 2027 | 2026-06-30 | -0.30 | 2026-08-14 | 10-Q |
| FY 2026 | 2026-03-31 | -1.83 | 2026-06-15 | 10-K |
| Q3 2026 | 2025-12-31 | -1.46 | 2026-02-12 | 10-Q |
| Q2 2026 | 2025-09-30 | -1.02 | 2025-11-13 | 10-Q |
| Q1 2027 | 2025-06-30 | -0.47 | 2026-08-14 | 10-Q |
| FY 2026 | 2025-03-31 | -1.67 | 2026-06-15 | 10-K |
| Q3 2026 | 2024-12-31 | -1.23 | 2026-02-12 | 10-Q |
| Q2 2026 | 2024-09-30 | -0.77 | 2025-11-13 | 10-Q |
| Q1 2026 | 2024-06-30 | -0.35 | 2025-08-07 | 10-Q |
| FY 2025 | 2024-03-31 | -1.52 | 2025-06-17 | 10-K |
| Q3 2025 | 2023-12-31 | -1.27 | 2025-02-13 | 10-Q |
| Q2 2025 | 2023-09-30 | -1.55 | 2024-11-07 | 10-Q |
| Q1 2025 | 2023-06-30 | -0.94 | 2024-08-13 | 10-Q |
| FY 2024 | 2023-03-31 | -8.51 | 2024-06-11 | 10-K |
| FY 2016 | 2016-03-31 | -29.08 | 2016-06-24 | 10-K |
| Q3 2016 | 2015-12-31 | -25.45 | 2016-02-16 | 10-Q |
| Q2 2016 | 2015-09-30 | -24.21 | 2015-11-16 | 10-Q |
| FY 2016 | 2015-03-31 | -10.61 | 2016-06-24 | 10-K |
| FY 2016 | 2014-12-31 | -1.08 | 2016-06-24 | 10-K |
| FY 2016 | 2014-09-30 | -1.90 | 2016-06-24 | 10-K |
| FY 2016 | 2014-06-30 | -3.70 | 2016-06-24 | 10-K |
| FY 2015 | 2014-03-31 | -3.81 | 2015-06-29 | 10-K |
| FY 2015 | 2013-12-31 | -0.44 | 2015-06-29 | 10-K |
| FY 2015 | 2013-09-30 | -1.37 | 2015-06-29 | 10-K |
| FY 2015 | 2013-06-30 | -0.44 | 2015-06-29 | 10-K |
| Q1 2014 | 2013-03-31 | -0.02 | 2014-08-12 | 10-Q |
| Q3 2013 | 2012-12-31 | -1.11 | 2014-02-14 | 10-Q |
| FY 2012 | 2012-09-30 | -0.11 | 2013-07-18 | 10-K |
| Q1 2013 | 2012-06-30 | -0.11 | 2013-08-14 | 10-Q |
| FY 2012 | 2012-03-31 | -0.83 | 2013-07-18 | 10-K |
| FY 2012 | 2011-12-31 | -0.28 | 2013-07-18 | 10-K |
| FY 2012 | 2011-09-30 | -0.15 | 2013-07-18 | 10-K |
| FY 2012 | 2011-06-30 | -0.22 | 2013-07-18 | 10-K |
| FY 2011 | 2011-03-31 | -1.81 | 2012-07-02 | 10-K |
| Q3 2011 | 2010-12-31 | -1.13 | 2012-02-14 | 10-Q |
| Q2 2011 | 2010-09-30 | -0.49 | 2011-11-14 | 10-Q |
| Q1 2011 | 2010-06-30 | -0.19 | 2011-08-22 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.